Skip to content

Safety and Efficacy Evaluation of S (+) - Ketamine in Adults

Safety and Efficacy Evaluation of S(+)-Ketamine for Postoperative Acute Pain in Adults in Perioperative Settings: A Multicenter, Randomized, Open-label, Active Controlled Pragmatic Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04837170
Enrollment
12000
Registered
2021-04-08
Start date
2021-05-01
Completion date
2022-06-30
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults, Anesthesia, Postoperative Pain

Keywords

S-ketamine,Esketamine,S (+) - ketamine, Acute Pain, Depression, Anxiety, Delirium, Hyperalgesia

Brief summary

A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in adults in perioperative settings.

Detailed description

Patients often suffer acute pain after operation ,which may affect the recovery. Opioid such as morphine is the most commonly analgesic drugs, but opioid has many obviously adverse reactions ,for example respiratory depression,circulation inhibition,tolerance, addiction, nausea, vomiting, pruritus, etc. S (+) - ketamine has been described to decrease acute pain and opioid consumption,but it needs to confirm for chinese patients undergoing surgery. Objective:Evaluate the efficacy and safety of S (+) - ketamine on acute perioperative pain for chinese adult patients,and look for the best dosage, mode of administration, timing, and compatibility ,as well explore the effect of S (+) - ketamine on postoperative delirium,anxiety ,depression and cognitive dysfunction.

Interventions

Patients who undergo general anesthesia using S(+)-ketamine hydrochloride for anesthesia induction,maintenance or postoperative analgesia.

DRUGConventional therapy

Receiving conventional therapy without S (+)-Ketamine hydrochloride injection. There is no restrictions in drugs, doses and incompatibility, the researchers can choose appropriate medication regimens based on clinical practice, but other NMDA receptor antagonists are not be allowed to use, such as dextromethorphan and amantadine.

Sponsors

Jiangsu Provincial People's Hospital
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Renmin Hospital of Wuhan University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Shengjing Hospital
CollaboratorOTHER
Southern Medical University, China
CollaboratorOTHER
Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Experimental group : Control group=2:1

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\. Age ≥18 years old; * 2\. Scheduled for elective digestive tract surgery, gynecological surgery, urological surgery, thoracic surgery, orthopedic limb surgery, orthopedic spine surgery or body surface surgery (thyroid surgery or breast surgery), head and neck surgery; * 3\. ASA score Ⅰ~Ⅲ; * 4\. The informed consent form was signed by the patients.

Exclusion criteria

* 1\. The expected length of hospital stay of the patient is less than 48h; * 2\. Patients expected to be admitted to the ICU after surgery; * 3\. Patients expected to return to the ward with tracheal catheter after surgery; * 4\. Be allergic to S (+) - ketamine; * 5\. Patients with severe disorder of consciousness or mental system diseases (schizophrenia, mania, bipolar disorder, psychosis, etc.) or cognitive dysfunction; * 6\. Patients with a history of severe cardiovascular disease (congestive heart failure, severe angina attack, or unstable angina or myocardial infarction within 6 months); * 7\. Patients during pregnancy or lactation; * 8\. Patients with MMSE score \<18 points; * 9\. Patients with any of the following contraindications of S (+) - ketamine: 1. Patients with risk of serious rise of blood pressure or intracranial pressure; 2. Patients with high intraocular pressure (glaucoma) or penetrating ocular trauma; 3. Patients with poorly controlled or untreated hypertension (Resting systolic blood pressure greater than 180 mmHg, or resting diastolic blood pressure greater than 100mmHg); 4. Patients with untreated or undertreated hyperthyroidism.

Design outcomes

Primary

MeasureTime frameDescription
The area under the broken line of NRS scoreHour 0-48 after surgeryThe score of Numerical Rating Scale(NRS) is 0-10, the higher the score, the more severe the pain.
Opioid consumptionHour 0-48 after surgeryTotal opioid consumption(conversion to equivalent morphine)

Secondary

MeasureTime frameDescription
The incidence of rescue analgesiaHour 0-48 after surgeryThe incidence of rescue analgesia within 48h after surgery
Recovery timeDay 0The time from the end of the operation to recovery(can be awakened)
The incidence of unexpected intraoperative eventsIntraoperativeUnexpected events during operation include intraoperative cough, laryngeal spasm, body movement, tachycardia,decreased oxygen saturation, respiratory depression, bradycardia, hypertension and hypotension.
The Patient Efficacy Questionnaire (IPOQ ) scoresHour 48 after surgeryPatient Efficacy Questionnaire (IPOQ ) scale include 13 questions , each question's score is 0-10 or 0-100%, it involves postoperative pain, mood and quality of life. The higher the score, the more severe the pain symptoms.
NRS pain scoresHour 0-48 after surgeryThe score of Numerical Rating Scale(NRS) is 0-10, the higher the score, the more severe the pain.
Pharmacoeconomic indicatorsHour 48 after surgeryCalculating incremental cost-effectiveness ratio (ICER)based on cost-effectiveness analysis.
Incidence of postoperative deliriumHour 0-48 after surgeryThe Chinese version of the 3D-CAM scale is used for the diagnosis of delirium, and the assessment will be carried out at 24h, 48h and 72h after the operation. If the patient is discharged 72h after the patient is discharged, it may not be assessed.
Simple Mental State Examination (MMSE) Scale scoreHour 48 after surgeryThe total score of Simple Mental State Examination Scale (MMSE) is 30,the higher the score, the better the cognitive function.
Hospital Anxiety and Depression (HAD) Scale scoreHour 48 after surgeryHospital Anxiety and Depression Scale (HAD) includes anxiety measure(7questions,0-21pionts) and depression measure(7 questions,0-21pionts),the higher the score, the more severe thesymptoms.
The incidence of adverse events after surgeryHour 0-48 after surgeryThe incidence of adverse events from the end of the operation to 48h after surgery. Including nausea, vomiting, increased secretions, dizziness, oversedation, infection,anesthetic awareness, nightmares, restlessness, pruritus, disorientation, delirium, respiratory depression, diplopia, diarrhea, intestinal obstruction, urinary retention, gastroesophageal reflux, constipation, chills, hallucinations, etc.
Time of first rescue analgesiaHour 0-48 after surgeryThe time from the end of the operation to the first rescue analgesics after the operation. Rescue analgesia refers to the analgesia according to the patient's requirements in addition to routine postoperative analgesia.

Contacts

Primary ContactWeidong Mi, MD
wwdd1962@aliyun.com8613381082966
Backup ContactHong Wang, MD
301wh@163.com8613661363231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026